Researchers at Stony Brook University developed an oral vaccine using modified Listeria monocytogenes that generates anti-tumor immune responses in the gut and significantly improves colorectal cancer control when combined with checkpoint inhibitors.
New research shows the nervous system contributes to pancreatic cancer development before tumors fully form, with nerve fibers and support cells creating a self-sustaining loop that promotes cancer growth. Blocking nerve activity reduced tumor growth by nearly 50% in experiments.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05854563 |
Cough Capture as a Portal Into the Lung |
RECRUITING | |
| NCT04724720 |
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19 |
ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04469556 |
Pancreatic Adenocarcinoma Signature Stratification for Treatment |
COMPLETED | PHASE2 |
| NCT04389567 |
Famotidine Outpatient COVID-19 Treatment Study |
COMPLETED | |
| NCT04387786 |
Dornase Alfa Administered to Patients With COVID-19 (DACOVID) |
COMPLETED | |
| NCT03410030 |
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) |
COMPLETED | PHASE1/PHASE2 |
| NCT02727023 |
Effect of OMM on Anandamide Levels in Saliva |
COMPLETED | NA |
| NCT02241187 |
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection |
COMPLETED | NA |
| NCT01219829 |
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma |
COMPLETED | |
| NCT00996710 |
Genomic Structural Variation in Cancer Susceptibility |
ACTIVE_NOT_RECRUITING |
